Symbol:
Ogn
Name:
osteoglycin
RGD ID:
1308171
Description:
Predicted to enable growth factor activity. Involved in negative regulation of smooth muscle cell proliferation. Predicted to be located in endoplasmic reticulum. Predicted to be active in extracellular matrix. Orthologous to human OGN (osteoglycin); INTERACTS WITH 17alpha-ethynylestradiol; 2,3,7,8-tetrachlorodibenzodioxine; 2,3,7,8-Tetrachlorodibenzofuran.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
LOC291015; mimecan; NEWGENE_1308171
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
OGN (osteoglycin) HGNC
EggNOG, Ensembl, HomoloGene, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Mus musculus (house mouse):
Ogn (osteoglycin) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Ogn (osteoglycin) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
OGN (osteoglycin) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
OGN (osteoglycin) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Ogn (osteoglycin) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
OGN (osteoglycin) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
OGN (osteoglycin) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Ogn (osteoglycin) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Homo sapiens (human):
OGN (osteoglycin)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Ogn (osteoglycin)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
ogna
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
ognb
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER)
Xenopus tropicalis (tropical clawed frog):
ogn
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|PANTHER)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 17 15,238,500 - 15,259,167 (-) NCBI GRCr8 mRatBN7.2 17 15,032,069 - 15,052,626 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 17 15,032,069 - 15,052,739 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 17 14,919,266 - 14,939,703 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 17 16,524,322 - 16,544,765 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 17 14,846,060 - 14,866,498 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 17 14,607,442 - 14,628,274 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 17 15,447,716 - 15,467,359 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 17 14,607,442 - 14,627,937 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 17 17,506,166 - 17,527,131 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 17 20,987,029 - 21,007,525 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 17 20,987,030 - 21,007,504 (-) NCBI Celera 17 14,763,600 - 14,783,780 (-) NCBI Celera Cytogenetic Map 17 p14 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Ogn Rat (2,4,5-trichlorophenoxy)acetic acid decreases expression ISO Ogn (Mus musculus) 6480464 2 more ... CTD PMID:18579281 Ogn Rat 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of OGN mRNA CTD PMID:17351261 Ogn Rat 17alpha-ethynylestradiol multiple interactions ISO Ogn (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of OGN mRNA CTD PMID:17942748 Ogn Rat 17alpha-ethynylestradiol increases expression ISO Ogn (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of OGN mRNA CTD PMID:17942748 Ogn Rat 17beta-estradiol increases expression ISO Ogn (Mus musculus) 6480464 Estradiol results in increased expression of OGN mRNA CTD PMID:19484750 Ogn Rat 17beta-estradiol increases expression ISO OGN (Homo sapiens) 6480464 Estradiol results in increased expression of OGN mRNA CTD PMID:25878060 Ogn Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Ogn (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of OGN mRNA and Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of OGN mRNA] CTD PMID:16054899 and PMID:17942748 Ogn Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of OGN mRNA CTD PMID:34747641 Ogn Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Ogn (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of OGN mRNA CTD PMID:33956508 Ogn Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of OGN mRNA CTD PMID:32109520 Ogn Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO OGN (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of OGN mRNA CTD PMID:30203000 Ogn Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Ogn (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of OGN mRNA CTD PMID:15034205 Ogn Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Ogn (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of OGN mRNA CTD PMID:21570461 Ogn Rat 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 Ogn Rat 2,4,6-tribromophenol decreases expression ISO OGN (Homo sapiens) 6480464 2 more ... CTD PMID:31675489 Ogn Rat 2,4-diaminotoluene decreases expression ISO Ogn (Mus musculus) 6480464 2 and 4-diaminotoluene results in decreased expression of OGN mRNA CTD PMID:20713471 Ogn Rat 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression ISO OGN (Homo sapiens) 6480464 2 more ... CTD PMID:26705709 Ogn Rat 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO Ogn (Mus musculus) 6480464 2 more ... CTD PMID:38648751 Ogn Rat 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of OGN mRNA CTD PMID:21346803 Ogn Rat 2-hydroxypropanoic acid increases expression ISO OGN (Homo sapiens) 6480464 Lactic Acid results in increased expression of OGN mRNA CTD PMID:30851411 Ogn Rat 3,3',5,5'-tetrabromobisphenol A decreases expression ISO Ogn (Mus musculus) 6480464 tetrabromobisphenol A results in decreased expression of OGN mRNA CTD PMID:25172293 Ogn Rat 3,7-dihydropurine-6-thione decreases expression EXP 6480464 Mercaptopurine results in decreased expression of OGN mRNA CTD PMID:23358152 Ogn Rat 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO Ogn (Mus musculus) 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of OGN mRNA and Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of OGN mRNA] CTD PMID:16054899 Ogn Rat 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO OGN (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of OGN mRNA CTD PMID:28628672 Ogn Rat 3-methylcholanthrene decreases expression ISO Ogn (Mus musculus) 6480464 Methylcholanthrene results in decreased expression of OGN mRNA CTD PMID:20713471 Ogn Rat 4,4'-sulfonyldiphenol increases expression ISO Ogn (Mus musculus) 6480464 bisphenol S results in increased expression of OGN mRNA CTD PMID:30951980 Ogn Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of OGN mRNA CTD PMID:24780913 Ogn Rat 7,12-dimethyltetraphene decreases expression EXP 6480464 9 more ... CTD PMID:19480007 Ogn Rat acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of OGN mRNA CTD PMID:28959563 Ogn Rat aldrin decreases expression ISO Ogn (Mus musculus) 6480464 Aldrin results in decreased expression of OGN mRNA CTD PMID:18579281 Ogn Rat antirheumatic drug increases expression ISO OGN (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of OGN mRNA CTD PMID:24449571 Ogn Rat arsenous acid decreases expression ISO OGN (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of OGN mRNA CTD PMID:26705709 Ogn Rat benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of OGN mRNA CTD PMID:21839799 Ogn Rat benzo[a]pyrene decreases expression ISO Ogn (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of OGN mRNA CTD PMID:15034205 Ogn Rat benzo[a]pyrene increases expression ISO Ogn (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of OGN mRNA CTD PMID:22228805 Ogn Rat bisphenol A decreases expression ISO Ogn (Mus musculus) 6480464 bisphenol A results in decreased expression of OGN mRNA CTD PMID:20739668 Ogn Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of OGN mRNA CTD PMID:38750585 Ogn Rat bisphenol A increases expression ISO Ogn (Mus musculus) 6480464 bisphenol A results in increased expression of OGN mRNA CTD PMID:30951980 more ... Ogn Rat bisphenol A multiple interactions ISO OGN (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of OGN mRNA CTD PMID:28628672 Ogn Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of OGN mRNA CTD PMID:25181051 Ogn Rat bisphenol F increases expression ISO Ogn (Mus musculus) 6480464 bisphenol F results in increased expression of OGN mRNA CTD PMID:30951980 Ogn Rat cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of OGN mRNA CTD PMID:25993096 Ogn Rat carbon nanotube decreases expression ISO Ogn (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 Ogn Rat CGP 52608 multiple interactions ISO OGN (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to OGN gene] CTD PMID:28238834 Ogn Rat cisplatin multiple interactions ISO OGN (Homo sapiens) 6480464 [Cisplatin co-treated with Paclitaxel] results in increased expression of OGN mRNA CTD PMID:20705681 Ogn Rat cobalt atom decreases expression ISO Ogn (Mus musculus) 6480464 Cobalt results in decreased expression of OGN mRNA CTD PMID:34468815 Ogn Rat copper(II) sulfate decreases expression ISO Ogn (Mus musculus) 6480464 Copper Sulfate results in decreased expression of OGN mRNA CTD PMID:18579281 Ogn Rat coumarin decreases expression EXP 6480464 coumarin results in decreased expression of OGN mRNA CTD PMID:18480146 Ogn Rat crocidolite asbestos decreases expression ISO Ogn (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of OGN mRNA CTD PMID:29279043 Ogn Rat Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of OGN mRNA CTD PMID:26577399 Ogn Rat cyclosporin A decreases expression ISO OGN (Homo sapiens) 6480464 Cyclosporine results in decreased expression of OGN mRNA CTD PMID:33631201 Ogn Rat decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of OGN mRNA CTD PMID:23914054 Ogn Rat dexamethasone multiple interactions ISO Ogn (Mus musculus) 6480464 [Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of OGN mRNA and Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of OGN mRNA] CTD PMID:16054899 Ogn Rat dexamethasone multiple interactions ISO OGN (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of OGN mRNA CTD PMID:28628672 Ogn Rat diarsenic trioxide decreases expression ISO OGN (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of OGN mRNA CTD PMID:26705709 Ogn Rat diazinon increases expression EXP 6480464 Diazinon results in increased expression of OGN mRNA CTD PMID:29108742 Ogn Rat dibutyl phthalate increases expression ISO Ogn (Mus musculus) 6480464 Dibutyl Phthalate results in increased expression of OGN mRNA CTD PMID:21266533 Ogn Rat dimethylarsinic acid decreases expression EXP 6480464 Cacodylic Acid results in decreased expression of OGN mRNA CTD PMID:37567419 Ogn Rat dioxygen multiple interactions ISO Ogn (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of OGN mRNA CTD PMID:30529165 Ogn Rat dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of OGN mRNA CTD PMID:33729688 Ogn Rat diuron decreases expression EXP 6480464 Diuron results in decreased expression of OGN mRNA CTD PMID:21551480 and PMID:25152437 Ogn Rat doxorubicin decreases expression ISO OGN (Homo sapiens) 6480464 Doxorubicin results in decreased expression of OGN mRNA CTD PMID:29803840 Ogn Rat endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of OGN mRNA CTD PMID:29391264 Ogn Rat epoxiconazole decreases expression ISO Ogn (Mus musculus) 6480464 epoxiconazole results in decreased expression of OGN mRNA CTD PMID:35436446 Ogn Rat furan increases expression EXP 6480464 furan results in increased expression of OGN mRNA CTD PMID:27387713 Ogn Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of OGN mRNA CTD PMID:33387578 Ogn Rat glycidol decreases expression EXP 6480464 glycidol results in decreased expression of OGN mRNA CTD PMID:24915197 Ogn Rat glyphosate decreases expression EXP 6480464 Glyphosate results in decreased expression of OGN mRNA CTD PMID:26302742 Ogn Rat graphene oxide decreases expression ISO Ogn (Mus musculus) 6480464 graphene oxide results in decreased expression of OGN mRNA CTD PMID:33227293 Ogn Rat indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of OGN mRNA CTD PMID:21396975 Ogn Rat indometacin multiple interactions ISO OGN (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of OGN mRNA CTD PMID:28628672 Ogn Rat lipopolysaccharide multiple interactions ISO OGN (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 Ogn Rat mercaptopurine decreases expression EXP 6480464 Mercaptopurine results in decreased expression of OGN mRNA CTD PMID:23358152 Ogn Rat methotrexate decreases expression ISO OGN (Homo sapiens) 6480464 Methotrexate results in decreased expression of OGN mRNA CTD PMID:17400583 Ogn Rat mono(2-ethylhexyl) phthalate increases expression ISO OGN (Homo sapiens) 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of OGN mRNA CTD PMID:36314267 Ogn Rat N-nitrosodiethylamine increases expression ISO Ogn (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of OGN mRNA CTD PMID:24535843 Ogn Rat nickel atom decreases expression ISO OGN (Homo sapiens) 6480464 Nickel results in decreased expression of OGN mRNA CTD PMID:25583101 Ogn Rat orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of OGN mRNA CTD PMID:23665939 Ogn Rat oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of OGN mRNA CTD PMID:25729387 Ogn Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of OGN mRNA CTD PMID:25729387 Ogn Rat ozone decreases expression ISO Ogn (Mus musculus) 6480464 Ozone results in decreased expression of OGN mRNA CTD PMID:12763052 Ogn Rat ozone multiple interactions ISO Ogn (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of OGN mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of OGN mRNA CTD PMID:34911549 Ogn Rat paclitaxel multiple interactions ISO OGN (Homo sapiens) 6480464 [Cisplatin co-treated with Paclitaxel] results in increased expression of OGN mRNA CTD PMID:20705681 Ogn Rat paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of OGN mRNA CTD PMID:33387578 Ogn Rat paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of OGN mRNA CTD PMID:32680482 Ogn Rat phenylephrine decreases expression EXP 6480464 Phenylephrine results in decreased expression of OGN mRNA CTD PMID:18158353 Ogn Rat potassium dichromate increases expression ISO Ogn (Mus musculus) 6480464 Potassium Dichromate results in increased expression of OGN mRNA CTD PMID:23608068 Ogn Rat purine-6-thiol decreases expression EXP 6480464 Mercaptopurine results in decreased expression of OGN mRNA CTD PMID:23358152 Ogn Rat rac-lactic acid increases expression ISO OGN (Homo sapiens) 6480464 Lactic Acid results in increased expression of OGN mRNA CTD PMID:30851411 Ogn Rat rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of OGN mRNA CTD PMID:27900601 and PMID:28374803 Ogn Rat S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO OGN (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 Ogn Rat S-(1,2-dichlorovinyl)-L-cysteine increases expression ISO OGN (Homo sapiens) 6480464 S-(1 and 2-dichlorovinyl)cysteine results in increased expression of OGN mRNA CTD PMID:35811015 Ogn Rat serpentine asbestos decreases expression ISO Ogn (Mus musculus) 6480464 Asbestos and Serpentine results in decreased expression of OGN mRNA CTD PMID:16251409 Ogn Rat silver atom decreases expression ISO Ogn (Mus musculus) 6480464 Silver results in decreased expression of OGN mRNA CTD PMID:27131904 Ogn Rat silver(0) decreases expression ISO Ogn (Mus musculus) 6480464 Silver results in decreased expression of OGN mRNA CTD PMID:27131904 Ogn Rat sirolimus increases expression EXP 6480464 Sirolimus results in increased expression of OGN mRNA CTD PMID:21865292 Ogn Rat sodium arsenite increases expression ISO OGN (Homo sapiens) 6480464 sodium arsenite results in increased expression of OGN mRNA CTD PMID:17879257 Ogn Rat sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of OGN mRNA and sodium arsenite results in decreased expression of OGN protein CTD PMID:19072884 and PMID:29459688 Ogn Rat sodium arsenite increases expression ISO Ogn (Mus musculus) 6480464 sodium arsenite results in increased expression of OGN mRNA CTD PMID:18812580 Ogn Rat sodium fluoride decreases expression ISO Ogn (Mus musculus) 6480464 Sodium Fluoride results in decreased expression of OGN mRNA CTD PMID:27862939 Ogn Rat sulforaphane decreases expression ISO Ogn (Mus musculus) 6480464 sulforaphane results in decreased expression of OGN mRNA CTD PMID:30529165 Ogn Rat tacrolimus hydrate increases expression EXP 6480464 Tacrolimus results in increased expression of OGN mRNA CTD PMID:21865292 Ogn Rat tacrolimus hydrate increases expression ISO Ogn (Mus musculus) 6480464 Tacrolimus results in increased expression of OGN mRNA CTD PMID:29362864 Ogn Rat tadalafil increases expression ISO Ogn (Mus musculus) 6480464 Tadalafil results in increased expression of OGN mRNA CTD PMID:32513693 Ogn Rat tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of OGN mRNA CTD PMID:16239168 Ogn Rat tetrachloromethane affects expression ISO Ogn (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of OGN mRNA CTD PMID:17484886 Ogn Rat titanium dioxide decreases expression ISO Ogn (Mus musculus) 6480464 titanium dioxide results in decreased expression of OGN mRNA CTD PMID:23557971 and PMID:27760801 Ogn Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of OGN mRNA CTD PMID:25729387 Ogn Rat topotecan increases expression EXP 6480464 Topotecan results in increased expression of OGN mRNA CTD PMID:25729387 Ogn Rat triclosan increases expression ISO OGN (Homo sapiens) 6480464 Triclosan results in increased expression of OGN mRNA CTD PMID:30510588 Ogn Rat trimellitic anhydride decreases expression ISO Ogn (Mus musculus) 6480464 trimellitic anhydride results in decreased expression of OGN mRNA CTD PMID:19042947 Ogn Rat troglitazone increases expression ISO Ogn (Mus musculus) 6480464 troglitazone results in increased expression of OGN mRNA CTD PMID:28973697 Ogn Rat valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of OGN mRNA CTD PMID:24136188 Ogn Rat valproic acid increases expression ISO Ogn (Mus musculus) 6480464 Valproic Acid results in increased expression of OGN mRNA CTD PMID:24896083 Ogn Rat vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of OGN mRNA CTD PMID:19015723 Ogn Rat vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of OGN mRNA CTD PMID:20566332
(2,4,5-trichlorophenoxy)acetic acid (ISO) 17alpha-ethynylestradiol (EXP,ISO) 17beta-estradiol (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,3,7,8-Tetrachlorodibenzofuran (EXP) 2,4,6-tribromophenol (ISO) 2,4-diaminotoluene (ISO) 2,4-dibromophenyl 2,4,5-tribromophenyl ether (ISO) 2,6-dinitrotoluene (EXP) 2-hydroxypropanoic acid (ISO) 3,3',5,5'-tetrabromobisphenol A (ISO) 3,7-dihydropurine-6-thione (EXP) 3-isobutyl-1-methyl-7H-xanthine (ISO) 3-methylcholanthrene (ISO) 4,4'-sulfonyldiphenol (ISO) 6-propyl-2-thiouracil (EXP) 7,12-dimethyltetraphene (EXP) acrylamide (EXP) aldrin (ISO) antirheumatic drug (ISO) arsenous acid (ISO) benzo[a]pyrene (EXP,ISO) bisphenol A (EXP,ISO) bisphenol F (ISO) cadmium dichloride (EXP) carbon nanotube (ISO) CGP 52608 (ISO) cisplatin (ISO) cobalt atom (ISO) copper(II) sulfate (ISO) coumarin (EXP) crocidolite asbestos (ISO) Cuprizon (EXP) cyclosporin A (ISO) decabromodiphenyl ether (EXP) dexamethasone (ISO) diarsenic trioxide (ISO) diazinon (EXP) dibutyl phthalate (ISO) dimethylarsinic acid (EXP) dioxygen (EXP,ISO) diuron (EXP) doxorubicin (ISO) endosulfan (EXP) epoxiconazole (ISO) furan (EXP) gentamycin (EXP) glycidol (EXP) glyphosate (EXP) graphene oxide (ISO) indole-3-methanol (EXP) indometacin (ISO) lipopolysaccharide (ISO) mercaptopurine (EXP) methotrexate (ISO) mono(2-ethylhexyl) phthalate (ISO) N-nitrosodiethylamine (ISO) nickel atom (ISO) orphenadrine (EXP) oxaliplatin (EXP) ozone (ISO) paclitaxel (ISO) paracetamol (EXP) paraquat (EXP) phenylephrine (EXP) potassium dichromate (ISO) purine-6-thiol (EXP) rac-lactic acid (ISO) rotenone (EXP) S-(1,2-dichlorovinyl)-L-cysteine (ISO) serpentine asbestos (ISO) silver atom (ISO) silver(0) (ISO) sirolimus (EXP) sodium arsenite (EXP,ISO) sodium fluoride (ISO) sulforaphane (ISO) tacrolimus hydrate (EXP,ISO) tadalafil (ISO) tetrachloromethane (EXP,ISO) titanium dioxide (ISO) topotecan (EXP) triclosan (ISO) trimellitic anhydride (ISO) troglitazone (ISO) valdecoxib (EXP) valproic acid (ISO) vinclozolin (EXP)
Ogn Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 17 15,238,500 - 15,259,167 (-) NCBI GRCr8 mRatBN7.2 17 15,032,069 - 15,052,626 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 17 15,032,069 - 15,052,739 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 17 14,919,266 - 14,939,703 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 17 16,524,322 - 16,544,765 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 17 14,846,060 - 14,866,498 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 17 14,607,442 - 14,628,274 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 17 15,447,716 - 15,467,359 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 17 14,607,442 - 14,627,937 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 17 17,506,166 - 17,527,131 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 17 20,987,029 - 21,007,525 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 17 20,987,030 - 21,007,504 (-) NCBI Celera 17 14,763,600 - 14,783,780 (-) NCBI Celera Cytogenetic Map 17 p14 NCBI
OGN Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 9 92,383,268 - 92,404,699 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 9 92,383,268 - 92,404,696 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 9 95,145,550 - 95,166,981 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 9 94,186,070 - 94,206,758 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Celera 9 65,588,282 - 65,608,970 (-) NCBI Celera Cytogenetic Map 9 q22.31 NCBI HuRef 9 64,823,710 - 64,844,399 (-) NCBI HuRef CHM1_1 9 95,292,689 - 95,313,376 (-) NCBI CHM1_1 T2T-CHM13v2.0 9 104,549,769 - 104,571,196 (-) NCBI T2T-CHM13v2.0
Ogn Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 13 49,761,491 - 49,777,977 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 13 49,761,522 - 49,777,977 (+) Ensembl GRCm39 Ensembl GRCm38 13 49,608,015 - 49,624,501 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 13 49,608,046 - 49,624,501 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 13 49,703,440 - 49,719,869 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 13 49,620,008 - 49,636,437 (+) NCBI MGSCv36 mm8 Celera 13 50,698,836 - 50,715,265 (+) NCBI Celera Cytogenetic Map 13 A5 NCBI cM Map 13 25.34 NCBI
Ogn Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955515 5,372,034 - 5,389,954 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955515 5,372,225 - 5,389,954 (+) NCBI ChiLan1.0 ChiLan1.0
OGN Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 11 47,023,831 - 47,045,720 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 9 47,026,287 - 47,048,803 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 9 63,505,165 - 63,527,761 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 9 91,578,833 - 91,600,741 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 9 91,578,833 - 91,600,738 (-) Ensembl panpan1.1 panPan2
OGN Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 1 98,939,374 - 98,959,173 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 1 98,939,429 - 98,957,543 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 1 99,333,213 - 99,353,015 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 1 99,556,194 - 99,575,993 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 1 99,555,768 - 99,627,336 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 1 99,169,271 - 99,189,070 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 1 98,904,553 - 98,924,354 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 1 99,661,321 - 99,681,130 (+) NCBI UU_Cfam_GSD_1.0
Ogn Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024404944 7,813,284 - 7,827,902 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936487 2,028,948 - 2,044,387 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936487 2,029,755 - 2,043,242 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
OGN Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 3 42,116,526 - 42,135,939 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 3 42,116,521 - 42,135,940 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 3 43,250,528 - 43,259,180 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
OGN Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 12 102,908,482 - 102,928,956 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 12 102,908,479 - 102,928,827 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666038 91,180,673 - 91,201,156 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Ogn
.
Assembly: mRatBN7.2
Chromosome Start Pos End Pos Reference Nucleotide Variant Nucleotide Variant Type Strain Variant Page
17
15051696
15051697
G
A
snv
FXLE16/Stm (2020) , LEXF7C/StmMcwi (2022), LEXF2B/Stm (2019), LEXF3/Stm (2020), LEXF4/Stm (2020), LE/Stm (2019), FXLE20/StmMcwi (2023), FXLE23/StmMcwi (2023), FXLE14/StmMcwi (2023), FXLE14/Stm (2019NG), FXLE20/Stm (2019NG), FXLE23/Stm (2022), LEXF1C/StmMcwi (2021), LEXF7A/Stm (2019NG), LEXF7B/StmMcwi (2022), LEXF1C/Stm (2019) View more Information
17
15052617
15052618
G
C
snv
F344/DuCrl (2019) , F344/NCrl (2019), F344/N (2020), F344/Stm (2019), FHH/EurMcwi (2019), FXLE18/Stm (2020), LEW/Crl (2019), LEXF11/Stm (2020), LEXF1A/Stm (2019), LH/MavRrrcAek (2020), LL/MavRrrcAek (2020), LN/MavRrrcAek (2020), LEXF10A/StmMcwi (2020), SR/JrHsd (2020), SS/JrHsdMcwi (2019), WAG/RijCrl (2020), WN/N (2020), F344/DuCrl (2019NG), F344/DuCrl (2019NG), F344/DuCrl (2021), European Variation Archive Release 3, European Variation Archive Release 4, LEXF2A/StmMcwi (2023), FXLE26/StmMcwi (2023), FXLE22/StmMcwi (2023), LEXF8D/StmMcwi (2023), LEXF10C/StmMcwi (2023), FXLE17/StmMcwi (2023), LEXF6B/StmMcwi (2023), FXLE15/StmMcwi (2023), FXLE21/StmMcwi (2023), FXLE13/StmMcwi (2023), LEXF5/StmMcwi (2023), FXLE25/StmMcwi (2023), FXLE12/StmMcwi (2023), European Variation Archive Release 6, F344/NHsd (2021), F344/StmMcwi (2019), FHH/EurMcwi (2019NG), FXLE12/StmMcwi (2021), FXLE12/Stm (2019NG), FXLE13/Stm (2019NG), FXLE15/StmMcwi (2021), FXLE15/Stm (2019NG), FXLE17/Stm (2019NG), FXLE19/StmMcwi (2022), FXLE23/Stm (2022), FXLE25/Stm (2022), FXLE26/Stm (2022), LEW/Crl (2019NG), LEXF10B/StmMcwi (2022), LEXF10C/Stm (2022), LEXF2A/Stm (2022), LEXF2C/StmMcwi (2022), LEXF5/Stm (2019NG), LEXF6B/Stm (2019NG), LEXF8A/StmMcwi (2021), LEXF8D/Stm (2022), LEXF9/StmMcwi (2022), SS/HsdMcwiCrl (2021), SS/JrHsdMcwi (2019NG), SS/JrHsd (2021) View more Information
Predicted Target Of
Count of predictions: 901 Count of miRNA genes: 285 Interacting mature miRNAs: 357 Transcripts: ENSRNOT00000020532, ENSRNOT00000072490 Prediction methods: Microtar, Miranda, Pita, Rnahybrid, Targetscan Result types: miRGate_prediction
1354581 Bp247 Blood pressure QTL 247 4.5 arterial blood pressure trait (VT:2000000) pulse pressure (CMO:0000292) 17 1 69599340 Rat 2300002 Iddm36 Insulin dependent diabetes mellitus QTL 36 1.98 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 17 9991286 40540197 Rat 631499 Stl1 Serum triglyceride level QTL 1 3.6 blood triglyceride amount (VT:0002644) blood triglyceride level (CMO:0000118) 17 3271398 27389946 Rat 2293664 Bmd28 Bone mineral density QTL 28 5.1 0.0001 femur mineral mass (VT:0010011) trabecular volumetric bone mineral density (CMO:0001729) 17 4354487 27028127 Rat 1300123 Bp194 Blood pressure QTL 194 2.82 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 17 2115149 34551001 Rat 1582224 Epfw4 Epididymal fat weight QTL 4 3.5 0.0058 epididymal fat pad mass (VT:0010421) epididymal fat pad weight to body weight ratio (CMO:0000658) 17 9201365 23653323 Rat 1582225 Bw67 Body weight QTL 67 6.2 0.0001 body mass (VT:0001259) body weight (CMO:0000012) 17 9201365 23653323 Rat 1582226 Bw64 Body weight QTL 64 4.2 0.0017 body mass (VT:0001259) body weight (CMO:0000012) 17 9201365 23653323 Rat 1354651 Lmblg2 Limb length QTL 2 6 tibia length (VT:0004357) tibia length (CMO:0000450) 17 4299130 69599340 Rat 10401807 Kidm52 Kidney mass QTL 52 kidney mass (VT:0002707) both kidneys wet weight (CMO:0000085) 17 1 31701463 Rat 10054088 Scort28 Serum corticosterone level QTL 28 2.04 0.0102 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 17 4528038 49528038 Rat 1354630 Cm34 Cardiac mass QTL 34 8.7 heart left ventricle mass (VT:0007031) heart left ventricle wet weight (CMO:0000071) 17 4299130 69599340 Rat 1582208 Kidm32 Kidney mass QTL 32 3.9 0.0018 kidney mass (VT:0002707) both kidneys wet weight (CMO:0000085) 17 9201365 23653323 Rat 1354638 Insul1 Insulin level QTL 1 4.8 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 17 4299130 69599340 Rat 1549900 Iddm20 Insulin dependent diabetes mellitus QTL 20 3.7 pancreas integrity trait (VT:0010560) percentage of study population developing diabetes mellitus during a period of time (CMO:0001114) 17 13986773 21975515 Rat 1354613 Kidm14 Kidney mass QTL 14 6.2 kidney mass (VT:0002707) left kidney wet weight (CMO:0000083) 17 4299130 35837242 Rat 2324619 Coatc4 Coat color QTL 4 0.001 coat/hair pigmentation trait (VT:0010463) pigmented dorsal coat/hair area to total dorsal coat/hair area ratio (CMO:0001811) 17 4299130 21293263 Rat 2303627 Vencon8 Ventilatory control QTL 8 0.001 respiration trait (VT:0001943) tidal volume (CMO:0000222) 17 4528038 49528038 Rat 70184 BpQTLcluster14 Blood pressure QTL cluster 14 3.38 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 17 1 31990913 Rat 1581553 Pur14 Proteinuria QTL 14 5.3 0.0001 urine total protein amount (VT:0000032) urine protein excretion rate (CMO:0000759) 17 7979968 16317111 Rat 2303561 Bw91 Body weight QTL 91 2 body mass (VT:0001259) body weight (CMO:0000012) 17 8868462 53868462 Rat 1582258 Bw76 Body weight QTL 76 4.6 0.0005 body mass (VT:0001259) body weight (CMO:0000012) 17 9201365 23653323 Rat 631207 Niddm41 Non-insulin dependent diabetes mellitus QTL 41 blood glucose amount (VT:0000188) plasma glucose level (CMO:0000042) 17 1 37830672 Rat 1582199 Insul5 Insulin level QTL 5 3.4 0.0119 blood insulin amount (VT:0001560) calculated serum insulin level (CMO:0000359) 17 9201365 23653323 Rat 1354596 Bw32 Body weight QTL 32 4.5 body mass (VT:0001259) body weight (CMO:0000012) 17 4299130 60781592 Rat 1354662 Rf49 Renal function QTL 49 2.9 blood creatinine amount (VT:0005328) plasma creatinine level (CMO:0000537) 17 1 69599340 Rat 2293648 Bmd31 Bone mineral density QTL 31 4.5 0.0001 femur size trait (VT:1000369) femoral neck cortical cross-sectional area (CMO:0001702) 17 4354487 27028127 Rat 1354658 Spl8 Serum phospholipid level QTL 8 3.8 blood VLDL phospholipid amount (VT:0010507) blood very low density lipoprotein phospholipid level (CMO:0001571) 17 1 60781592 Rat 1641902 Colcr7 Colorectal carcinoma resistance QTL 7 3.35 0.0044 intestine integrity trait (VT:0010554) benign colorectal tumor surface area measurement (CMO:0001799) 17 2115149 21881669 Rat 1582241 Bw70 Body weight QTL 70 4.6 0.0003 body mass (VT:0001259) body weight (CMO:0000012) 17 9201365 23653323 Rat 1582245 Bw73 Body weight QTL 73 4.6 0.0004 body mass (VT:0001259) body weight (CMO:0000012) 17 9201365 23653323 Rat 9590316 Scort21 Serum corticosterone level QTL 21 4.75 0.001 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 17 1 22871563 Rat
RH139253
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 17 15,032,432 - 15,032,646 (+) MAPPER mRatBN7.2 Rnor_6.0 17 14,607,806 - 14,608,019 NCBI Rnor6.0 Rnor_6.0 17 15,448,080 - 15,448,293 NCBI Rnor6.0 Rnor_5.0 17 17,506,530 - 17,506,743 UniSTS Rnor5.0 Rnor_5.0 17 16,660,127 - 16,660,340 UniSTS Rnor5.0 RGSC_v3.4 17 20,987,393 - 20,987,606 UniSTS RGSC3.4 Celera 17 14,763,964 - 14,764,177 UniSTS RH 3.4 Map 17 179.4 UniSTS Cytogenetic Map 17 p14 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
15
11
83
192
145
140
97
31
97
12
348
149
160
79
106
43
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000020532 ⟹ ENSRNOP00000020532
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 17 15,032,069 - 15,052,566 (-) Ensembl Rnor_6.0 Ensembl 17 14,607,442 - 14,627,937 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000072490 ⟹ ENSRNOP00000065601
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source Rnor_6.0 Ensembl 17 15,448,986 - 15,467,320 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000093561 ⟹ ENSRNOP00000076332
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 17 15,032,072 - 15,052,739 (-) Ensembl Rnor_6.0 Ensembl 17 15,447,716 - 15,467,359 (-) Ensembl
RefSeq Acc Id:
NM_001106103 ⟹ NP_001099573
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 17 15,238,500 - 15,258,995 (-) NCBI mRatBN7.2 17 15,032,069 - 15,052,566 (-) NCBI Rnor_6.0 17 14,607,442 - 14,627,937 (-) NCBI Rnor_5.0 17 17,506,166 - 17,527,131 (-) NCBI RGSC_v3.4 17 20,987,029 - 21,007,525 (-) RGD Celera 17 14,763,600 - 14,783,780 (-) RGD
Sequence:
TCAGCAGTTTGAAGCAATTCCACAGCTTTGCTCATTCACTCTCCCACTTGGGACTAATGCACAGGAAAACTCAGGGACTTCAACCAGATACTACGGGAAAAAAGAGGTTTGTTCCACAGTCATCAGGT
hide sequence
RefSeq Acc Id:
XM_008771490 ⟹ XP_008769712
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 17 15,238,500 - 15,259,167 (-) NCBI mRatBN7.2 17 15,032,069 - 15,052,626 (-) NCBI Rnor_6.0 17 14,607,442 - 14,628,274 (-) NCBI
Sequence:
TTCTCATTAAATTAAGAACAAAGACTATGCTCAGTTTGGTGTTCTATTTCATTCAAAAGTAAATGTCTTCTATACCAGAAAGGCACAAAAATAAAGGCCAGATTTTAAAAAGATTTATAAACTAGCAT
hide sequence
RefSeq Acc Id:
XM_063276149 ⟹ XP_063132219
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 17 15,238,500 - 15,259,166 (-) NCBI
RefSeq Acc Id:
NP_001099573 ⟸ NM_001106103
- Peptide Label:
precursor
- UniProtKB:
D3ZVB7 (UniProtKB/TrEMBL), A6J6V8 (UniProtKB/TrEMBL)
- Sequence:
MKTVHPTLLLLLFVPLTQQTPQTQLDSHVNSKYGTDNSEETKFIQDYEDKYLDGKNIKEKETMIIPDEKSLQLQKDEVIPSVPTKKENDEMPTCLLCVCLSGSVYCEEVDIDAVPPLPKESAYLYARF
hide sequence
RefSeq Acc Id:
XP_008769712 ⟸ XM_008771490
- Peptide Label:
isoform X1
- UniProtKB:
A0A1W2Q6Q0 (UniProtKB/TrEMBL)
- Sequence:
MESAVEFHMGVKLLGPETLFSSLKQFHSFAHSLSHLGLMHRKTQGLQPDTTVPWEDFDCTQYLY
hide sequence
Ensembl Acc Id:
ENSRNOP00000065601 ⟸ ENSRNOT00000072490
Ensembl Acc Id:
ENSRNOP00000076332 ⟸ ENSRNOT00000093561
Ensembl Acc Id:
ENSRNOP00000020532 ⟸ ENSRNOT00000020532
RefSeq Acc Id:
XP_063132219 ⟸ XM_063276149
- Peptide Label:
isoform X1
- UniProtKB:
A0A1W2Q6Q0 (UniProtKB/TrEMBL)
RGD ID: 13700342 Promoter ID: EPDNEW_R10866 Type: initiation region Name: Ogn_1 Description: osteoglycin SO ACC ID: SO:0000170 Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ ) Experiment Methods: Single-end sequencing. Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 17 14,627,935 - 14,627,995 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2021-03-09
Ogn
osteoglycin
NEWGENE_1308171
osteoglycin
Data merged from RGD:11378586
737654 PROVISIONAL
2016-08-02
NEWGENE_1308171
osteoglycin
Symbol and Name status set to provisional
70820 PROVISIONAL
2008-04-07
Ogn
osteoglycin
Ogn_predicted
osteoglycin (predicted)
Symbol and Name updated
1299863 APPROVED
2005-01-12
Ogn_predicted
osteoglycin (predicted)
Symbol and Name status set to approved
70820 APPROVED
